0000950170-24-056082.txt : 20240508 0000950170-24-056082.hdr.sgml : 20240508 20240508191846 ACCESSION NUMBER: 0000950170-24-056082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240506 FILED AS OF DATE: 20240508 DATE AS OF CHANGE: 20240508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DelAversano Robert J CENTRAL INDEX KEY: 0001728262 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35776 FILM NUMBER: 24928014 MAIL ADDRESS: STREET 1: 217 W. MAIN STREET CITY: SOMERVILLE STATE: NJ ZIP: 08876 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acasti Pharma Inc. CENTRAL INDEX KEY: 0001444192 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-649-9272 MAIL ADDRESS: STREET 1: 103 CARNEGIE CENTER STREET 2: SUITE 300 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 ownership.xml 4 X0508 4 2024-05-06 0001444192 Acasti Pharma Inc. ACST 0001728262 DelAversano Robert J 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 false true false false Principal Financial Officer false Stock Options (Right to Buy) 2.96 2024-05-06 4 A false 4500 0 A 2034-05-06 Class A Common Shares 4500 4500 D Stock options granted on 05/06/2024 under the Acasti Pharma Stock Option Plan, which vest quarterly in equal installments over a 36-month period. /s/ Robert J. DelAversano 2024-05-08